Company Filing History:
Years Active: 2023
Title: Innovations in Aortic Aneurysm Treatment by Peter Costandi
Introduction
Peter Costandi is an innovative inventor based in Irvine, CA, who has made significant contributions to the field of medical technology. He is known for his work in developing methods to improve patient outcomes following endovascular treatments. His expertise and dedication to advancing medical procedures have led to the creation of a notable patent.
Latest Patents
Peter Costandi holds a patent titled "Modulation of inflammatory response following endovascular treatment." This patent describes a method for treating an aortic aneurysm using an endovascular graft system. The method involves placing at least one prosthesis across an aneurysmal space, which consists of a double-walled filling structure and a stent-graft. The stent-graft is radially expanded at a first pressure, and the filling structure is filled with a first filling agent to contact a thrombus in the aortic aneurysmal space. After the first filling agent is removed, a second filling agent is used to further contact the thrombus. The stent-graft is then expanded at a second pressure, applying effective pressure on the thrombus and mitigating the effects of post-implant syndrome associated with the prosthesis. This innovative approach aims to enhance the safety and efficacy of endovascular treatments.
Career Highlights
Peter Costandi is currently associated with Endologix, Inc., a company dedicated to developing innovative solutions for vascular diseases. His work at Endologix has allowed him to focus on improving treatment options for patients suffering from aortic aneurysms. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical technology.
Collaborations
Throughout his career, Peter has collaborated with talented professionals in the field, including Mohammed Arif Iftekhar and Carlos Ortega. These collaborations have fostered an environment of innovation and have led to the development of cutting-edge medical solutions.
Conclusion
Peter Costandi's contributions to the field of medical technology, particularly in the treatment of aortic aneurysms, highlight his commitment to improving patient care. His innovative patent and work at Endologix, Inc. demonstrate the impact of his expertise in advancing medical procedures.